Company intelligence / Profile preview

Korea Biochem Pharm

South Korea

Ownership: Private
Development stage: Other

Overview

Korea Biochem Pharm is an active pharmaceutical ingredient (API) and finished product supplier established in 2010, exporting globally and providing approximately 30–55 commercial-grade APIs and finished drug products, including regulatory support services. Clinical trial innovation or novel drug development is not reported; the company focuses on quality manufacturing and supply of approved APIs and generic finished formulations.[1][3][5][9][10]

Therapeutic areas: NeurologyEndocrinologyCardiovascularGastroenterology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Korea Biochem Pharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Korea Biochem Pharm.

Explore the full profile